Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Butera

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Journal of Medicinal Chemistry|March 29, 2000
Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 2. Selective and potent benzylamino cyclobutenedionesA M Gilbert, M M Antane, T M Argentieri, et al.
Scientific Reports|April 5, 2020
Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus ErythematosusR Lande, R Palazzo, N Gestermann, et al.
Breast (Edinburgh, Scotland)|August 31, 2019
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 studyM E Cazzaniga, G Pinotti, E Montagna, et al.
Scientific Reports|July 28, 2023
Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patientsB Trevisan, F F Pepe, I Vallini, et al.
Breast Cancer Research and Treatment|September 21, 2021
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 studyM E Cazzaniga, I Vallini, E Montagna, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Journal of Medicinal Chemistry|March 29, 2000
Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 2. Selective and potent benzylamino cyclobutenedionesA M Gilbert, M M Antane, T M Argentieri, et al.
Scientific Reports|April 5, 2020
Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus ErythematosusR Lande, R Palazzo, N Gestermann, et al.
Breast (Edinburgh, Scotland)|August 31, 2019
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 studyM E Cazzaniga, G Pinotti, E Montagna, et al.
Scientific Reports|July 28, 2023
Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patientsB Trevisan, F F Pepe, I Vallini, et al.
Breast Cancer Research and Treatment|September 21, 2021
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 studyM E Cazzaniga, I Vallini, E Montagna, et al.
Pageof 7